248
edits
mNo edit summary Tag: 2017 source edit |
mNo edit summary Tag: 2017 source edit |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox drug | {{Infobox drug | ||
| other_names = | | other_names = gamma-hydroxybutyric acid | ||
GBL (gamma-butyrolactone) | |||
BDO (1,4-butanediol) | |||
| image_file = | | image_file = | ||
| image_caption = | | image_caption = | ||
| Line 10: | Line 12: | ||
}} | }} | ||
''' | '''GHB''' (also known as '''''gamma''-hydroxybutyric acid'''), is a depressant used recreationally for its alcohol-like effects. Related drugs such as '''GBL''' (''gamma''-butyrolactone) and '''BDO''' (1,4-butanediol) are pro-drugs of GHB (meaning that the body's metabolism turns them into actual GHB). These drugs produce very similar effects to GHB, but have important differences in their dosing, time to onset of effects, and duration of action. | ||
== Background<!-- Provide background information for this drug. --> == | == Background<!-- Provide background information for this drug. --> == | ||